Literature DB >> 17693581

Absence of regulatory T-cell control of TH1 and TH17 cells is responsible for the autoimmune-mediated pathology in chronic graft-versus-host disease.

Xiao Chen1, Sanja Vodanovic-Jankovic, Bryon Johnson, Melissa Keller, Richard Komorowski, William R Drobyski.   

Abstract

Graft-versus-host disease (GVHD) remains the major complication after allogeneic bone marrow transplantation (BMT). The process whereby acute GVHD mediated by alloreactive donor T cells transitions into chronic GVHD, which is characterized by prominent features of auto-immunity, has long been unresolved. In this study, we demonstrate that GVHD-associated autoimmunity and, by extension, chronic GVHD is attributable to the progressive loss of CD4(+)CD25(+)Foxp3(+) regulatory T cells during the course of acute GVHD. This leads to the expansion of donor-derived CD4(+) T cells with T(H)1 and T(H)17 cytokine phenotypes that release proinflammatory cytokines and cause autoimmune-mediated pathological damage. These T cells are present early after transplantation, indicating that the pathophysiological events that lead to chronic GVHD are set in motion during the acute phase of GVHD. We conclude that the absence of CD4(+)CD25(+) regulatory T cells coupled with unregulated T(H)1 and T(H)17 cells leads to the development of autoimmunity and that donor-derived T(H)1 and T(H)17 cells serve as the nexus between acute and chronic GVHD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17693581      PMCID: PMC2077325          DOI: 10.1182/blood-2007-05-091074

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  54 in total

1.  Autoimmunity after allogeneic bone marrow transplantation. A study of 53 long-term-surviving patients.

Authors:  A M Rouquette-Gally; D Boyeldieu; A C Prost; E Gluckman
Journal:  Transplantation       Date:  1988-08       Impact factor: 4.939

2.  Decreased interleukin 10 and increased interferon-gamma production in patients with chronic graft-versus-host disease after allogeneic bone marrow transplantation.

Authors:  D Körholz; D Kunst; L Hempel; D Söhngen; A Heyll; H Bönig; U Göbel; F Zintl; S Burdach
Journal:  Bone Marrow Transplant       Date:  1997-04       Impact factor: 5.483

3.  Autoimmune hemolytic anemia following T cell-depleted allogeneic bone marrow transplantation.

Authors:  W R Drobyski; J Potluri; D Sauer; J L Gottschall
Journal:  Bone Marrow Transplant       Date:  1996-06       Impact factor: 5.483

4.  Cytokine expression in human cutaneous chronic graft-versus-host disease.

Authors:  L A Ochs; B R Blazar; J Roy; E B Rest; D J Weisdorf
Journal:  Bone Marrow Transplant       Date:  1996-06       Impact factor: 5.483

5.  Serum cytokine levels in bone marrow transplantation: synergistic interaction of interleukin-6, interferon-gamma, and tumor necrosis factor-alpha in graft-versus-host disease.

Authors:  M Imamura; S Hashino; H Kobayashi; S Kubayashi; S Hirano; T Minagawa; J Tanaka; Y Fujii; M Kobayashi; M Kasai
Journal:  Bone Marrow Transplant       Date:  1994-06       Impact factor: 5.483

6.  Hyperacute graft-versus-host disease accompanied by increased serum interleukin-6 levels.

Authors:  M Imamura; S Hashino; S Kobayashi; H Kobayashi; J Tanaka; K Imai; M Kasai; K Sakurada; T Miyazaki
Journal:  Int J Hematol       Date:  1994-07       Impact factor: 2.490

7.  Generation of CD4+ cytotoxic T-lymphocyte clones from a patient with severe graft-versus-host disease after allogeneic bone marrow transplantation: implications for graft-versus-leukemia reactivity.

Authors:  L M Faber; S A van Luxemburg-Heijs; W F Veenhof; R Willemze; J H Falkenburg
Journal:  Blood       Date:  1995-10-01       Impact factor: 22.113

8.  Cytokine dysregulation in chronic graft versus host disease.

Authors:  V Barak; F Levi-Schaffer; B Nisman; A Nagler
Journal:  Leuk Lymphoma       Date:  1995-03

9.  T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines.

Authors:  F Fossiez; O Djossou; P Chomarat; L Flores-Romo; S Ait-Yahia; C Maat; J J Pin; P Garrone; E Garcia; S Saeland; D Blanchard; C Gaillard; B Das Mahapatra; E Rouvier; P Golstein; J Banchereau; S Lebecque
Journal:  J Exp Med       Date:  1996-06-01       Impact factor: 14.307

10.  CD4+ T cells that express high levels of CD45RB induce wasting disease when transferred into congenic severe combined immunodeficient mice. Disease development is prevented by cotransfer of purified CD4+ T cells.

Authors:  P J Morrissey; K Charrier; S Braddy; D Liggitt; J D Watson
Journal:  J Exp Med       Date:  1993-07-01       Impact factor: 14.307

View more
  102 in total

1.  Targeting Sirt-1 controls GVHD by inhibiting T-cell allo-response and promoting Treg stability in mice.

Authors:  Anusara Daenthanasanmak; Supinya Iamsawat; Paramita Chakraborty; Hung D Nguyen; David Bastian; Chen Liu; Shikhar Mehrotra; Xue-Zhong Yu
Journal:  Blood       Date:  2018-12-04       Impact factor: 22.113

2.  Emergence of T cells that recognize nonpolymorphic antigens during graft-versus- host disease.

Authors:  Hemalatha Rangarajan; Maryam Yassai; Hariharan Subramanian; Richard Komorowski; Megan Whitaker; Jack Gorski; William R Drobyski
Journal:  Blood       Date:  2012-04-10       Impact factor: 22.113

Review 3.  Immune regulatory cells in umbilical cord blood and their potential roles in transplantation tolerance.

Authors:  Young-June Kim; Hal E Broxmeyer
Journal:  Crit Rev Oncol Hematol       Date:  2010-08-19       Impact factor: 6.312

4.  CD8+ Foxp3+ regulatory T cells are induced during graft-versus-host disease and mitigate disease severity.

Authors:  Amy J Beres; Dipica Haribhai; Alexandra C Chadwick; Patrick J Gonyo; Calvin B Williams; William R Drobyski
Journal:  J Immunol       Date:  2012-05-30       Impact factor: 5.422

5.  Active thrombopoiesis is associated with worse severity and activity of chronic GVHD.

Authors:  T Bat; S M Steinberg; R Childs; K R Calvo; A J Barrett; M Battiwalla; K Baird; D Zhang; D Pulanic; C E Dunbar; S Z Pavletic
Journal:  Bone Marrow Transplant       Date:  2013-07-08       Impact factor: 5.483

6.  Host interleukin 6 production regulates inflammation but not tryptophan metabolism in the brain during murine GVHD.

Authors:  Ludovic Belle; Vivian Zhou; Kara L Stuhr; Margaret Beatka; Emily M Siebers; Jennifer M Knight; Michael W Lawlor; Casey Weaver; Misato Hashizume; Cecilia J Hillard; William R Drobyski
Journal:  JCI Insight       Date:  2017-07-20

7.  In vitro-differentiated TH17 cells mediate lethal acute graft-versus-host disease with severe cutaneous and pulmonary pathologic manifestations.

Authors:  Michael J Carlson; Michelle L West; James M Coghill; Angela Panoskaltsis-Mortari; Bruce R Blazar; Jonathan S Serody
Journal:  Blood       Date:  2008-10-28       Impact factor: 22.113

8.  Dendritic cells mediate the induction of polyfunctional human IL17-producing cells (Th17-1 cells) enriched in the bone marrow of patients with myeloma.

Authors:  Kavita M Dhodapkar; Scott Barbuto; Phillip Matthews; Anjli Kukreja; Amitabha Mazumder; David Vesole; Sundar Jagannath; Madhav V Dhodapkar
Journal:  Blood       Date:  2008-07-30       Impact factor: 22.113

9.  Interleukin 17 is not required for autoimmune-mediated pathologic damage during chronic graft-versus-host disease.

Authors:  Xiao Chen; Rupali Das; Richard Komorowski; Jacques van Snick; Catherine Uyttenhove; William R Drobyski
Journal:  Biol Blood Marrow Transplant       Date:  2009-09-17       Impact factor: 5.742

10.  Reciprocal differentiation and tissue-specific pathogenesis of Th1, Th2, and Th17 cells in graft-versus-host disease.

Authors:  Tangsheng Yi; Ying Chen; Lin Wang; Gong Du; Daniel Huang; Dongchang Zhao; Heather Johnston; James Young; Ivan Todorov; Dale T Umetsu; Lieping Chen; Yoichiro Iwakura; Fouad Kandeel; Stephen Forman; Defu Zeng
Journal:  Blood       Date:  2009-07-14       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.